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Introduction
Biliary atresia (BA) is defined as a progressive inflam-
matory, fibrotic, destructive-sclerosing process, continuous, 
which is complicated by endoluminal obliteration of the 
bile ducts both intra and extrahepatic [1]. Complicated with 
destructive cholangitis, it partially or totally affects the bili-
ary excretory system, and leads to continuous fibrosis of the 
biliary system, resulting in numerical reduction of the intra-
hepatic bile ducts with stenosis of the entire biliary excreto-
ry system, ending with biliary cirrhosis [1]. The pathology is 
determined by a pathogenetic, multifactorial complex that 
initiates inflammation, fibrosis, sclerosis and bile duct obli-
teration. Based on the etiopathogenetic evolution, BA is not 
the agenesis of the biliary system, but the continuation of 
the destructive processes conceived in both,  embryonic and 
fetal periods [1, 2].
Despite the detailed etiopathogenetic argumentation, 
some authors currently support the theory of biliary atre-
sia as an acquired notion. The justification for this theory 
is supported by statistical results that indicate that 35-40% 
of patients have normal meconium stool at birth, and more 
than 50% have colic stools at birth, and in the short postna-
tal period, being met periodicity of colic and acholic stools 
[1, 2].
The diagnostic differentiation in a short time creates di-
fficulties and imposes an interdisciplinary activity in order 
to exclude neonatal hepatitis, metabolic, hematological, ge-
netic disorders, etc., which can be easily confused with BA. 
The surgery on the background of the above-mentioned pa-
thologies, considerably aggravates the child’s condition and 
has an unfavorable prognosis [1, 3].
Histologically, it is demonstrated that in most cases the 
intrahepatic bile ducts are numerically diminished and the 
lack of the lumen is appreciated with the transformation of 
the bile ducts into connective tissue cords. In the specialized 
literature are described cases when in the fibrous cord the 
premature lumen of the bile ducts is appreciated. BA may be 
present as an isolated abnormality or in combination with 
other birth defects [1]. Fibrosis obliteration of the biliary 
system is directly proportional to the patient’s age, this fin-
ding raise major problems in the diagnostic differentiation 
from a histological point of view, with neonatal hepatitis. 
Multiple classifications based on the anatomy of these fibro-
us biliary ducts  have been carried out. It was found that 
most often the extrahepatic ductal system is obliterated, and 
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Background: Biliary atresia (BA) is a serious pediatric condition that tends to progress to cirrhosis, liver failure, and death within a short time. It is 
the result of a continuous inflammatory, sclerosing, destructive process in the biliary tract and the most common indication  for liver transplantation.
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2014-2019. The basic methods in the diagnosis of BA were the biochemical examination, FGDS, USG doppler dupplex color of the biliary system before 
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Results: Following the analysis of clinical and paraclinical results, surgical pathology was excluded in 25 patients, the diagnosis of BA was established 
in 11 cases. 6 patients with BA underwent  Kasai surgical intervention  ,  a primary liver transplant was performed in 3 cases, and 2 patients died before 
the surgery.
Conclusions: Portoenteroanastamosis ( Kasai operation) performed as early as possible (up to 60 days postnatal) considerably increases life expectancy. 
The embryonic form of BA is a severe condition that is indicated for the initial liver transplant.The prognosis of untreated biliary atresia is unfavorable, 
leading to the death of most children in the first 2 years of  life due to liver failure. In decopensated late-diagnosed cases, liver transplantation remains 
the only treatment option. 
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in 20% of cases the gallbladder, cystic duct, choledochus 
remain permeable. Children with biliary atresia are usually 
born at term with a weight within the norm [1, 3].
Morbidity accounts for 28-30% of all newborns with 
cholestasis, the incidence being from 1:8000 to 1:18000 live 
newborns, most often with sporadic occurrence in the ab-
sence of a positive family history [4].  In the eastern coun-
tries, such as Japan, China, Korea, Vietnam, Laos, etc., the 
disease is found in about 1:8000 children [5, 6]. The highest 
incidence was recorded in Taiwan 1:3000. More common in 
females, the ratio being 1.3:1 [6]. 
Annually in the USA there are over 400 cases of biliary 
atresia, mostly extrahepatic, with an incidence of 1:14000. It 
is found in Europe with an incidence of 1:16000 live births 
[6]. Annually in the Republic of Moldova 2-3 children are 
born with biliary atresia having an incidence for the years 
2014-2019 of 1:13000. In 2014, in Moldova, according to the 
statistics of the Republic of Moldova, 5 children were born 
with biliary atresia, the given frequency being inexplicable.
Material and methods
The clinical study was carried out at Natalia Gheorghiu 
Scientific Center of Pediatric Surgery on a group of 46 pa-
tients up to 1 year of age hospitalized with cholestasis syn-
drome during the years 2014-2019. The basic methods in 
diagnosing BA were the clinical manifestations, scalocolu-
rometry, biochemical examination, VGDS, USG doppler 
dupplex color of the biliary system before and after the 
meals, cholangiographic MRI, dynamic hepatobiliary scin-
tigraphy, and liver biopsy.
Results
Following the analysis of clinical and paraclinical results, 
surgical pathology was excluded in 25 patients, the diagno-
sis of  BA was established in 11 patients, 6 girls and 5 boys 
(fig. 1, 2).  
Fig. 1.  Incidence of BA for patients with cholestasis
6 patients with BA underwent Kasai surgery, in 3 pa- 
tients  a primary liver transplant was performed, and 2 pa- 
tients died before surgery.
In eight children there was a meconium stool, in 3 chil-
dren postnatal there was an acholic stool. Subsequently, 
all children experienced symptoms no less important than 
acholic stools and hyperchromic urine. Eight children were 
born at term, one child at 34 weeks, 2 at 36 weeks. Body 
weight at birth ranged from 2500 g to 3800 g.
BA was established according to the following results, 
the primary sign for  diagnosis confirmation  was prolonged 
to cholestatic jaundice, persistent in the first weeks of life, 
being present in 100% of examined patients. Neonatal jaun-
dice was reported in two children (4.3%).
The initial objective examination revealed mild hepa-
tomegaly with dynamic liver enlargement and pronounced 
splenomegaly, pruritus, coagulopathy and hemorrhagic 
syndrome manifested by frequent petechiae and bruising. 
Ascites and pronounced vascular pattern on the abdominal 
wall was assessed in the late stage of the disease or in a ge-
neral decompensated state. Palpation of the liver revealed 
induration with a rounded edge; splenomegaly was assessed 
in the case of intrahepatic  portal hypertension (PH).
Scalocolurometry was performed in all patients for at 
least 14 days and repeated as needed. Initially, all patients 
had an acholic stool, in 4 patients there was a change in the 
yellow color for 2-3 defecations, with subsequent installation 
of acholic stool. In 3 patients the acholic stool was followed 
by the presence of black stools, which indicate an association 
of complications and the presence of coagulopathy.
Special attention was drawn to the laboratory findings 
Fig. 2.  gender prevalence in children with BA
Fig. 3. Type of treatment for pacience whith BA
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to the fractions of bilirubin, mainly to direct bilirubin, 
which in cases of BA was considerably increased, showing 
values  from 180-420 mcmol/l, persistent after conservative 
treatment, and regressing only after the  Kasai successful in-
tervention.  It should be noted that the prevalence of direct 
bilirubin is predominantly characteristic in the early stages 
of the pathology, whereas in case of hepatocellular involve-
ment the increased direct bilirubin is not so obvious com-
pared to indirect bilirubin. Moreover, sometimes indirect 
bilirubin may prevail, which requires careful analysis for di-
agnostic differentiation. In addition to increased bilirubin, 
elevated levels of transaminases, GGTP, increased alkaline 
phosphatase, lactase hydrogenase, cholesterol, amylase, be-
talipoprotein, phospholipids, 5 nucleotidase, and decreased 
indices of prothrombin, fibrinogen, disorder of the synthesis 
function of albumin and total proteins with an increased co-
agulation time were reported.
It is important to mention that in case of BA, the abo-
ve-mentioned indices show a slight decrease following the 
infusion treatment, though these do not return to normal 
values, which is an important fact in the diagnostic diffe-
rentiation. All patients were also tested for viral liver mar-
kers (HBs antigen, anti HBs antigen, HBcor, anti HCV, anti 
HBV, anti HDV), assessment of antibody levels of IgG, IgM 
classes to viral damage (papeloma virus, cytomegalovirus, 
ebstein- bar, rotavirus, type 3 RNA reovirus, human herpes 
virus type 6, shingles virus), alpha 1 antitrypsin (deficiency 
of which is indication for liver transplantation). CMV was 
recorded in 8 patients with BA. No other viral damage was 
reported.
Pre- and post-feeding abdominal ultrasound investiga-
tion was indicated in all patients. The examination was per-
formed during pre-feeding, 4 hours after the last feeding and 
40-50 min post-feeding. Gallbladder aplasia was diagnosed 
in 7 patients and dysfunctional gallbladder with anatomi-
cal location and extrahepatic bile ducts with a fibrous band 
appearance was found in 4 patients. It should be noted that 
intra- and extra-hepatic bile duct dilation was not recorded 
in any patient with BA.
Polysplenia was diagnosed in 2 children and congenital 
heart failure in 3 children. More information on liver paren-
chyma and the installation of intrahepatic PH was revealed 
by the doppler ultrasound examination, where 3 patients 
reported severe changes in the liver parenchyma-biliary 
cirrhosis with the installation of intrahepatic PH were ob-
served.
Videogastroduodenoscopy (VGDS) was performed to 
visualize the Vater papilla, describe the duodenal mucosa, 
assess the bile in the duodenum, as well as to provide a di-
fferential diagnosis. The presence of bile in the upper diges-
tive tract was not detected in all patients with BA. It should 
be mentioned that the duodenal jaundice mucosa can be 
confused with the presence of bile in the duodenum, which 
considerably transcends the medical-surgical tactics.
This study did not include the retrograde cholangiopan-
creatography, being mainly  based on USG, MRI and scinti-
graphy that show  a much lower harmful impact. We would 
like to mention that percutaneous cholangiography is an in-
vasive method and it is not recommended unless dilatations 
of the biliary tree are present.
Cholangiographic MRI was performed in all children 
with BA, which allowed the study of both intra- and extra-
hepatic bile ducts. The examination performed in 8 children 
showed obvious changes of the gallbladder, of which in 2 
children the intrahepatic location of the aplastic gallbladder 
was assessed. The virtual reconstruction of the biliary tree 
completed the previous examinations and played a decisive 
role in the differentiation of the diagnosis and the appreci-
ation of the medical-surgical tactics. At the same time, we 
would like to mention that as a result of the investigation 
we could not assess with certainty the biliary atresia and the 
degree of parenchymal damage, which indicates the need to 
establish the diagnosis in the context of correlating to all cli-
nical and paraclinical examinations.
Dynamic liver scintigraphy with Tc-99m isotopes (te-
chnetium 99m) was performed in a patient at whom  the 
accumulation of the pharmaceuticals within the liver and 
the lack of communication of the biliary tract with the du-
odenum was eloquently visualized. The presence of radio-
nuclide in the intestine confirms ductal permeability and 
excludes biliary atresia. Failure to visualize the tracer in the 
intestinal lumen more than 3-4 hours after administration, 
especially with phenobarbital, suggested a biliary obstructi-
on caused by biliary atresia. At the same time it should be 
mentioned that in premature infants with a body weight of 
less than 2000 g and on a full parenteral diet, the excretion 
of the pharmaceutical substances in the duodenum may be 
absent, and does not allow us to differentiate the diagno-
sis. It should be mentioned that the dynamic scintigraphy 
of the liver is superior to contrast examinations but due to 
a prolonged general anesthesia (3 hours) it complicated the 
investigation in newborns. To improve radioactive uptake, 
5 mg-kg phenobarbital should be administered daily for 5 
days prior to scintigraphy.
Transcutaneous hepatic puncture under ultrasound 
guidance was performed preoperatively in 6 children, in 
all cases there was a numerical decrease of the bile ducts 
with structural destruction and sclerosis of the bile duct, 
and transformation of the bile ducts into connective tissue 
cords. In persistent jaundice, percutaneous liver biopsy did 
not allow confirmation of  BA, by identifying liver fibrosis 
with bile duct proliferation, the presence of biliary plugs 
in the bile ducts in the liver triads; biliary stasis in canals 
and cells; edema and fibrosis in the hepatic triads; swelling, 
vacuolation and desquamation of the bile duct epithelium; 
inflammatory cellular infiltration; gigantocellular transfor-
mation of liver cells. The presence of biliary thrombi in the 
lumen of the interlobular bile ducts or of the primary ducts 
and the neoductular proliferation in the peripheral portal 
spaces indicate a certain occurence of BA, which helped us 
to make a differential diagnostic. 
Following the systematization of clinical, paraclinical 
and histological findings, the embryonic form of  BA was 
established in 4 children and  the perinatal form was found 
in 7 children (fig. 4).
Two children with embryonic form died during a pre-
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transplant, one child was diagnosed with BA  syndromatic 
type (Alagille syndrome), the other 10 children presented a 
nonsyndromatic type (fig. 5). 
Fig. 4.  Etiology prevalence for BA
Fig. 5. Types of  BA described within the study
An embryo-shaped child was initially subjected to liver 
transplantation and subsequently died at 6 months after 
transplant, and an embryonic-shaped child survived after 
transplant.
Two children were initially diagnosed with intracranial 
haemorrhage; 1 child was treated conservatively with sub-
sequent Kasai surgery, the other child underwent surgery 
and initial liver transplantation.
Preoperative management. General preoperative mea-
sures included parenteral administration of fat-soluble vita-
mins A, D, K, E; medium chain triglycerides as a source of 
fat (Lipofundin, SMOFlipid, etc.), desensitizers to alleviate 
skin itching. Vitamin K (1-2 mg / Kg / day) was administe-
red 3 days preoperatively. Oral feeding was ceased 12 hours 
preoperatively. For the preparation of the intestine = oral 
metronidazole, 10 mg / kg per day in two doses was admi-
nistered, as well as  the evacuation clyster (Carbo erbo gly-
cerol bambini) was applied. The patients were administered 
broad-spectrum antibiotics preoperatively and intraopera-
tively.
Treatment. The medical-surgical approach was aimed to 
restore the bile duct, by implementing two tactics: the Kasai 
surgical procedure and liver transplantation.
There are currently known over 6 BA classifications .
The medical-surgical tactics was assessed according to 
the classification of the Japanese Society of Pediatric Surgery 
which includes the following variants of atresia:
Type 1 – choledochal duct atresia
Type 2 – (a, b)
- 2a – atresia of the common hepatic duct
- 2b – atresia of the choledochus, hepatic duct, cystic 
duct and gallbladder with preservation of anastomoses, 
ducts in the hepatic hilum
Type 3 – atresia of the choledochal duct, hepatic duct 
and bile ducts of the hepatic hilum (without preservation 
of the anastomoses of the ducts in the hepatic hilum), in 
combination with atrophy of the gallbladder, without biliary 
content in the lumen.
All children from our study were diagnosed with type 
3 BA according to the Japanese classification. It should be 
mentioned  that it is very difficult to assess the level of bili-
ary atresia preoperatively, and only intraoperative cholan-
giography can suggest the true effect of bile ducts, which 
determines the type of biliodigestive anastamosis.
Portoenterostomy (Kasai surgery) was performed in 6 
patients. The surgery began with an extensive laparotomy 
approach, selected in each case. Other concomitant mal-
formations were initially ruled out. Subsequently, suturing 
and resection of the sickle ligament was performed in order 
to mobilize the liver and visualize the operating field. For 
demonstrative confirmation of the diagnosis, intraoperative 
cholangiography and thin-needle biopsy of the liver paren-
chyma, segment 6, 7, 8, and marginal biopsy were perfor-
med. Confirmation of  BA by intraoperative cholangiogra-
phy was followed by retrograde cholecystectomy with pre-
paration of fibrous cords in the liver gate and preparation of 
ductal plaque (fig. 6).
Fig. 6 . Intraoperator cholangiography
The left and right branch of the hepatic artery and the 
bifurcation of the portal vein served as the anatomical ori-
entation of the ductal plaque boundaries . Safety loops were 
applied to the right and left hepatic arteries in order to pro-
vide a broader view of the ductal plaque and prevent blee-
ding in case of an operating accident (fig. 7).
The preparation of the fibrous callus was performed by 
applying a fixator on the fibrous tissue and two other loops 
(fixators) on the hepatic arteries. It is important to mention 
that hemostasis by electrocoagulation was never used in the 
preparation of the ductal plaque.
The preparation of the hepatic arteries by the fibrous tis-
sue was performed until their branching into the hepatic tis-
sue, which represented the reference plan for the dissection 
of the ductal plaque.
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anterior lip was fixed with interrupted sutures with the sub-
sequent formation of a jejunal lumen (fig. 9).
Every second suture was made in the dorsal wall of the 
open jejunum, ensuring the widest possible anastamosis 
with the complete inclusion of the sectioned fibrous surface.
Postoperatively, early feeding was encouraged due to the 
stimulation of bile secretion and the favorable effect on liver 
function. Choleretic therapy with ursodeoxycholic acid (20-
30 mg / kg daily in 2 doses) was indicated throughout the 
postoperative year. Phenobarbital was indicated at a dose of 
5-10 mg/kg daily, for 30 days, in order to provide a prolon-
ged activation of the microsomal enzymes of the hepatocyte 
endoplasmic reticulum.
Nasogastric drainage was performed until the restorati-
on of intestinal function, which commonly lasted on avera-
Fig. 9.  Portoenteroanastomosis formation
(Posterior lip, prolen 6-0)
Fig. 7.  Ductal plaque preparation
Fig. 8.  Termino-lateral anastomosis formation
The success of the procedure was determined by the pre-
sence of microscopic permeability of the bile ducts. The 1st 
step finished by applying a buffer with 0.9% warm NaCl to 
the liver hilum, after an early irrigation. In 2 patients, the 
bile was removed with the naked eye, in which the Kasai 
procedure  might be  successfull at 2-2.5 years.
The jejunum, with its proximal section 20 cm from the 
Treitz ligament, was used to restore the integrity of the bi-
liary system and digestive tract and to prepare a Y-shaped 
Roux loop (fig 8).
The distal edge of the jejunum was closed by an inverted 
ligature. Subsequently, the termino-lateral jejunostomy was 
performed at 40-50 cm distance from the inverted edge of 
the distal jejunum ensuring intestinal continuity; the Roux 
loop was sutured cranially with the ilium at an angle of  6-8 
cm from the anastomosis, which in our view facilitates eva-
cuation of the gall and prevented the reflux from the ilion 
into the Roux loop. No  anti-reflux valves on the Roux loop 
were applied.
Portoenterostomy was initiated with the application of 
continuous and interrupted absorbable sutures 6-0 (prolen, 
PDS, polyglatil, maxon) with the application of two fixatives 
to the corner of the posterior lip, subsequently the poste-
rior lip was fixed with uninterrupted suture, whereas the 
ge for 48 hours. Intravenous antibiotics were administered 
during the enteral feeding, being continued with long-term 
administration of oral antibiotics. Anti-inflammatory drugs 
were gven for 21 days postoperatively. Homeostasis moni-
toring, general blood analysis, coagulogram, blood bioche-
mistry and urinalysis were performed daily until the home-
ostasis stabilized, then once a week.
In the postoperative period, adequate drainage of the 
bile ducts was obtained in 4 patients. The postoperative 
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period for one patient was complicated by sclerosing cho-
langitis and hepatic impairment. Adequate biliary drainage 
was not obtained in two patients, thus 3 patients required 
liver transplantation at 6 months, 8 months and 9 months 
postoperatively.
Two patients were late diagnosed – at 4.5-5 months and 
one patient with BA embryonic form underwent initial liver 
transplantation. Two patients died after liver transplantation.
Two patients who were late diagnosed and hospitalized 
in an extremely serious condition died preoperatively.
Discussion
Embryological development of the biliary system begins 
in the 4th week of the hepatic diverticulum of the anterior 
primitive intestine [7]. Subsequently, the differentiation of the 
cranial and caudal components takes place, namely: the pro-
ximal extrahepatic ducts and most of the intrahepatic biliary 
system develop from the cranial segment, and the gallblad-
der, cystic duct and choledochus from the caudal one [8].
Although bile duct atresia is often associated with other 
congenital abnormalities, suggesting prenatal pathogenesis, 
the presence of progressive inflammatory bile duct lesions 
in children with isolated biliary atresia suggests perinatal 
exposure to a harmful factor [9].
The combination of biliary atresia with other congenital 
anomalies is fully demonstrated, with rates ranging from 10 
to 50%. The most commonly reported cardiac abnormaliti-
es, persistence of the oval foramen, persistence of the arte-
rial duct, ventricular septal defect, splenic and gastrointesti-
nal abnormalities have been reported [10].
Each newborn-infant with cholestatic jaundice should 
be considered a patient with biliary atresia until the etiology 
is established [11]. To date, there is no true test that would 
differentiate between neonatal hepatitis (intrahepatic cho-
lestasis) and biliary atresia [12].
In the neonatal period on the 3rd day, unconjugated 
hyperbilirubinemia has a physiological character (physiolo-
gical jaundice). 2-15% of newborns retain this feature after 2 
weeks postnatal and are defined by prolonged physiological 
jaundice (14-24 days), and only 0.2-0.4% are present with 
mechanical jaundice, without liver cholestasis or other di-
sorders that would disrupt bile flow [12, 13]. Paradoxically, 
initially the most important indicator in the diagnosis of bi-
liary atresia in a child with conjugated hyperbilirubinemia 
is the general lack of clear symptoms and signs of hepatocel-
lular destruction [14].
Changes in scalocolurometry after administration of the 
needle test. Ursodeoxycholic allows us to differentiate the 
diagnostic of  BA from other liver pathologies complicated 
by cholestasis syndrome [15]. 
At  the age of  3 weeks in children with BA, bile excre-
tion is completely absent, which can be easily confirmed in 
VGDS. The resumption of biliary transit in case of a suc-
cessful Kasai intervention is recorded for up to 30 days, 
and liver function is restored for several years [16].  The 
accelerated dynamics of hepatocellular destruction is com-
plicated by biliary liver cirrhosis, intrahepatic PH, ascites, 
esophageal varices with upper digestive hemorrhage [17]. 
Malabsorption of fat-soluble vitamins contributes to the 
development of anemia, malnutrition, weight and psycho-
emotional retardation, rickets, xanthoma of the palms and 
knees, neuromuscular disorders [18]. 
Differential diagnosis. BA is a complicated and long-las-
ting process, due to the presence of a whole range of inflam-
matory, infectious, metabolic, genetic, syndromic, parasitic, 
specific pathologies, etc., which require a differential diagno-
sis [19, 20]. It is also necessary to differentiate the diagnosis 
with a series of very rare surgical pathologies, such as ob-
structive choledochal malformations, spontaneous perfora-
tion of the bile duct and hyperdense bile syndrome, congeni-
tal choledochal cyst, congenital liver fibrosis, etc. [19].
Therefore, ultrasonography and cholangiopancreatogra-
phy are used, which highlight the common bile duct with a 
considerably dilated diameter (usually > 5 mm) or congeni-
tal choledochal cyst with considerable modification of the 
excretory shaft [2].
Spontaneous biliary perforation is manifested by ultra-
sound and  by the presence of a small amount of fluid in the 
peritoneal cavity , as well as  the presence of an echogenic 
mass at the transverse fissure of the liver [20].
Viscous bile syndrome usually occurs in premature in-
fants. Ultrasound examination reveals a dilation of the bile 
duct, which contains hyperdense bile. In these cases, percuta-
neous cholangiography is performed and sometimes surgery 
to release the bile ducts from the obstruction [21]. The di-
fferential diagnosis is also made in various jaundice syndro-
mes, such as: drug damage to the liver, congenital transport 
disorders (Crigler-Najar, Rotor, Dubin-Jonson, galactose-
mia, tyrosinemia, alpha-1-antitrypsin deficiency), neonatal 
hepatitis with giant cells, cytomegalovirus hepatitis and cys-
tic fibrosis. Jaundice that persists during 30 days postnatally 
with the prevalence of conjugated bilurbine, 90% of cases are 
diagnosed as bile duct atresia. Jaundice due to hepatitis in the 
newborn is very difficult to differentiate [21, 22].
Liver biopsy, viral serology, and sweat testing are also 
performed for differential diagnosis. A diagnostic problem 
is biliary hypoplasia characteristic of Alagille syndrome, 
which can be misdiagnosed [22, 23].
The clinical features, such as specific facial expression, 
systolic murmur on the pulmonary artery (AP stenosis), 
spinal pathology or ophthalmic system may develop in pa-
tients with Alagille syndrome (cholestatic liver failure), but 
not in patients with extrahepatic bile duct atresia [23].
In biliary atresia the only solution is surgical treatment, 
general preoperative measures include parenteral adminis-
tration of fat-soluble vitamins A, D, K, E; medium chain tri-
glycerides as a source of fat (Lipofundin, SMOFlipid, etc.), 
desensitizers to alleviate skin itching [24]. Vitamin K (1-2 
mg / Kg / day) is administered 3 days preoperatively. Oral 
feeding is stopped for 8 hours preoperatively [24]. 
Kasai surgery is the treatment of choice for extrahepatic 
biliary atresia becoming the surgical standard in extrahepa-
tic biliary atresia, which was first performed in 1957 [25]. 
Kasai surgery is recommended in the first 90 days postnatal 
and only in extrahepatic forms of  BA [26, 27].
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The survival rate over 10 years after the Kasai procedure 
is 40-46% and continues to increase. Despite successful re-
sults worldwide, only 20-30% of patients survive until the 
age of 20 or more without a transplant [27].
The success of the Kasai procedure depends on the early 
diagnosis of  BA, the application of portoenterostomy up to 
a maximum of 90 days postnatal, strict adherence to the sur-
gical technique, prevention of complications and adequate 
postoperative monitoring [28]. 
Portoenterostomy should anticipate irreversible sclero-
sis of the intrahepatic bile ducts. Obtaining an obvious bilia-
ry flow of over 10mg of bilirubin per day can be appreciated 
as a success of surgical treatment [28, 29]. 
The rapid decrease of cholestatic syndrome with the re-
turn of biochemical indices within the norm in the first 6 
months postoperatively indicates a long-term survival, whi-
le the presence of jaundice up to 1 year with maintenance of 
hepatocellular destruction, suggests the need for a planned 
liver transplantation. A successful intervention might be 
assessed by the appearance of the stool in 2 weeks postope-
ratively, at 6 months the total bilirubin does not exceed 50 
mmol / l [29].
Many surgeons support the opinion of the initial liver 
transplant in children with biliary atresia, which would ex-
clude the long-term risk for the evaluation of Kasai surgery. 
Others propose an initial liver transplant, only in those pati-
ents in whom the diagnosis of biliary atresia was established 
more than 120 days after birth, or in those with unfavorable 
histological changes. Currently, the opinion of the initial 
Kasai intervention is mainly supported in the surgical wor-
ld, the liver transplant being an approach in cases of ineffici-
ency of portoenterostomy [30].
The success of the treatment depends on several factors, of 
paramount importance being the age at which the Kasai ope-
ration was performed. Another key to success is performing 
the operation in the first 100 days, after which liver decom-
pensation develops. However, it is difficult to estimate and 
predict treatment outcomes even in the first 40 days. Thus, 
the high rate of complications means that a large number of 
patients require a revision of the portoenterostomy [30].
The prognosis of untreated biliary atresia is unfavorable, 
leading to  the death of most children in the first 2 years 
of life due to liver failure. The Kasai procedure, although 
not definitive in all patients, increases life expectancy con-
siderably [31]. Survival at 5 years in patients without liver 
transplantation is approximately 30%. Thus, children with 
biliary atresia, in addition to the benefits of hepatoporto-
enteroanastomosis, also have a certain degree of residual 
liver failure, often with indications for liver transplantation. 
50% of children aged  5 years with normal biochemical in-
dications develop esophageal varices, and require endosco-
pic ligation,whereas  15% of them develop hemorrhages by 
varicose rash despite the  drug and endoscopic treatment. 
Biliary cirrhosis subsequently occurs in 10% of patients 
with normalized serum bilirubin, and liver transplantati-
on is indicated.The survival rate after Kasai surgery over 10 
years in children with normal clinical-paraclinical indices 
does not exceed 10% [32, 33].
The success of the Kasai procedure depends on several 
factors: the age at which the surgery was performed, the 
exact dissection and transection of the liver hilum, the seve-
rity of the liver pathology, the postoperative treatment per-
formed, and the occurrence of postoperative complications, 
especially cholangitis [33, 34].
The maintainance of acholic stools in the postoperati-
ve period and discontinued postoperative biliary excretion 
indicate an unfavorable prognosis. Death usually occurs wi-
thin 1 year. The surgery performed after the age of 90 days 
significantly influences the unfavorable prognosis due to the 
progression of the sclerosing-destructive process of the bile 
duct and advanced hepatocellular destruction [35].
Patients who did not resist  primary biliary drainage (15-
30%), develop progressive liver failure, the optimal treat-
ment being liver transplantation [36].
Conclusions
1. Biliary atresia is the most common cause of extra-
hepatic obstructive jaundice in newborns and is the most 
common indication for liver transplantation in children.
2. The embryonic form of  BA is a severe condition that 
is indicated for the initial liver transplant. In this form, 
Kasai surgery is not effective and creates impediments to 
liver transplantation.
3. Biliary atresia is a serious pediatric condition that 
tends to develop into cirrhosis, liver failure and death.
4. Portoenteroanastamosis (Kasai surgery) performed as 
early as possible (up to 60 days postnatal) significantly in-
creases the success of surgery.
5. The success of the Kasai procedure depends on seve-
ral factors: the age at which the surgery was performed, the 
exact dissection and transection of the liver hilum, the seve-
rity of the liver pathology, and the occurrence of postopera-
tive complications, especially cholangitis.
6. Liver transplantation remains the only treatment op-
tion in decopensated and late- diagnosed cases (over 120 
days), as well as in those showing complications in the post-
operative period resulting in liver failure.
7. The prognosis of untreated biliary atresia is unfavora-
ble resulting in  the death of most children in the first 2 years 
of life due to liver failure.
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